Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Ruhstaller, Thomas"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 118
Tytuł:
Is a change in patient-reported dysphagia after induction chemotherapy in locally advanced esophageal cancer a predictive factor for pathological response to neoadjuvant chemoradiation?
Autorzy:
Ribi, Karin
Koeberle, Dieter
Schuller, Jan C.
Honegger, Hanspeter
Roth, Arnaud
Hess, Viviane
Moosmann, Peter
von Moos, Roger
Borner, Markus
Lombriser, Norbert
Pestalozzi, Bernhard
Ruhstaller, Thomas
Pokaż więcej
Źródło:
Supportive Care in Cancer. August 2009 17(8):1109-1116
Czasopismo naukowe
Szczegóły
Tytuł:
Radiation recall dermatitis with soft tissue necrosis following pemetrexed therapy: a case report
Autorzy:
Spirig Christian
Omlin Aurelius
D'Addario Giannicola
Loske Klaus-Dieter
Esenwein Philipp
Geismar Jan
Ruhstaller Thomas
Pokaż więcej
Temat:
Medicine
Źródło:
Journal of Medical Case Reports, Vol 3, Iss 1, p 93 (2009)
Opis pliku:
electronic resource
Relacje:
http://www.jmedicalcasereports.com/content/3/1/93; https://doaj.org/toc/1752-1947
Dostęp URL:
https://doaj.org/article/66440ac484f64c18b7414ff59ae9813b  Link otwiera się w nowym oknie
Czasopismo naukowe
Szczegóły
Tytuł:
Endosonographic radial tumor thickness after neoadjuvant chemoradiation therapy to predict response and survival in patients with locally advanced esophageal cancer: a prospective multicenter phase ll study by the Swiss Group for Clinical Cancer ...
Autorzy:
Jost, Christian
Binek, Janek
Schuller, Jan C.
Bauerfeind, Peter
Metzger, Urs
Werth, Baseli
Knuchel, Juerg
Frossard, Jean-Louis
Bertschinger, Philipp
Brauchli, Peter
Meyenberger, Christa
Ruhstaller, Thomas
Pokaż więcej
Źródło:
Gastrointestinal Endoscopy; Jun2010, Vol. 71 Issue 7, p1114-1121, 8p
Czasopismo naukowe
Szczegóły
Tytuł:
Heated (37 degrees C) oxaliplatin infusion in combination with capecitabine for metastatic colorectal carcinoma: can it reduce neuropathy?
Autorzy:
Cathomas R (AUTHOR)
Köberle D (AUTHOR)
Ruhstaller T (AUTHOR)
Mayer G (AUTHOR)
Räss A (AUTHOR)
Mey U (AUTHOR)
von Moos R (AUTHOR)
Cathomas, Richard (AUTHOR)
Köberle, Dieter (AUTHOR)
Ruhstaller, Thomas (AUTHOR)
Mayer, Gisela (AUTHOR)
Räss, Andrea (AUTHOR)
Mey, Ulrich (AUTHOR)
von Moos, Roger (AUTHOR)
Pokaż więcej
Źródło:
Supportive Care in Cancer. Oct2010, Vol. 18 Issue 10, p1263-1270. 8p.
Czasopismo naukowe
Szczegóły
Tytuł:
Oesophageal cancer: exploring controversies overview of experts' opinions of Austria, Germany, France, Netherlands and Switzerland.
Autorzy:
Putora PM; Department of Radiation Oncology, Kantonsspital St. Gallen, 9007, St. Gallen, Switzerland. .
Bedenne L; University Hospital Le Bocage, Dijon, France Federation Francophone de Cancérologie Digestive (FFCD), Dijon, France. .
Budach W; Department of Radiation Oncology, Heinrich Heine University of Düsseldorf, German Oesophageal Study Group (GOSG), Düsseldorf, Germany. .
Eisterer W; Department of Internal Medicine V, Innsbruck Medical University, West-Austrian Study Group (AGMT), Innsbruck, Austria. .
Van Der Gaast A; Department of Medical Oncology, Erasmus University Medical Center, ChemoRadiotherapy for Oesophageal cancer versus Surgery alone Study Group (CROSS), Rotterdam, The Netherlands. .
Jäger R; Department of Radiation Oncology, Innsbruck Medical University, West-Austrian Study Group (AGMT), Innsbruck, Austria. .
Van Lanschot JJ; Department of Surgery, Erasmus University Medical Center, ChemoRadiotherapy for Oesophageal cancer versus Surgery alone Study Group (CROSS), Rotterdam, The Netherlands. .
Mariette C; Department of Digestive and Oncological Surgery, University Hospital Lille, Federation Francophone de Cancérologie Digestive (FFCD), Lille, France. .
Schnider A; Department of Surgery, City-Hospital Triemli, Swiss Group for Clinical Cancer Research (SAKK), Zurich, Switzerland. .
Stahl M; Kliniken Essen-Mitte, Klinik für Internistische Onkologie und Hämatologie, German Oesophageal Study Group (GOSG), Essen, Germany. .
Ruhstaller T; Department of Haematology and Oncology, Swiss Group for Clinical Cancer Research (SAKK), Kantonsspital St. Gallen, St. Gallen, Switzerland. thomas.ruhstaller@kssg.ch.
Pokaż więcej
Źródło:
Radiation oncology (London, England) [Radiat Oncol] 2015 May 21; Vol. 10, pp. 116. Date of Electronic Publication: 2015 May 21.
Typ publikacji:
Journal Article
MeSH Terms:
Disease Management*
Esophageal Neoplasms/*therapy
Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Chemoradiotherapy ; Consensus ; Diagnostic Imaging ; Dissent and Disputes ; Esophageal Neoplasms/diagnosis ; Esophagectomy/methods ; Europe ; Humans ; Multimodal Imaging ; Neoadjuvant Therapy ; Neoplasm Staging/methods ; Radiotherapy/methods ; Remission Induction ; Societies, Medical
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
SAKK 24/09: safety and tolerability of bevacizumab plus paclitaxel vs. bevacizumab plus metronomic cyclophosphamide and capecitabine as first-line therapy in patients with HER2-negative advanced stage breast cancer - a multicenter, randomized phase III trial.
Autorzy:
Rochlitz C; Department of Oncology, University Hospital Basel, Petersgraben 4, Basel, CH-4031, Switzerland. .
Bigler M; SAKK Coordinating Center, Bern, Switzerland.
von Moos R; Department of Oncology, Kantonsspital Graubünden, Chur, Switzerland.
Bernhard J; International Breast Cancer Study (IBCSG) and Inselspital, Bern University Hospital, Bern, Switzerland.
Matter-Walstra K; SAKK Coordinating Center, Bern, Switzerland and European Center for Pharmaceutical Medicine, University Basel, Basel, Switzerland.
Wicki A; Department of Oncology, University Hospital Basel, Petersgraben 4, Basel, CH-4031, Switzerland.
Zaman K; Department of Oncology, University Hospital Lausanne, Lausanne, Switzerland.
Anchisi S; Department of Oncology, Hospital of Valais, Sion, Switzerland.
Küng M; Department of Oncology, Kantonsspital Fribourg, Fribourg, Switzerland.
Na KJ; SAKK Coordinating Center, Bern, Switzerland.; Present Address: Novartis Pharma, Stein, Switzerland.
Bärtschi D; SAKK Coordinating Center, Bern, Switzerland.
Borner M; Department of Oncology, Spitalzentrum Biel, Biel, Switzerland.
Rordorf T; Department of Oncology, University Hospital Zürich, Zürich, Switzerland.
Rauch D; Department of Oncology, Spital STS, Thun, Switzerland.
Müller A; Department of Oncology, Kantonsspital Winterthur, Winterthur, Switzerland.
Ruhstaller T; Department of Oncology, Kantonsspital St. Gallen, St. Gallen, Switzerland.
Vetter M; Department of Oncology, University Hospital Basel, Petersgraben 4, Basel, CH-4031, Switzerland.
Trojan A; Department of Oncology, OnkoZentrum Zürich, Zürich, Switzerland.
Hasler-Strub U; Department of Oncology, Kantonsspital St. Gallen, St. Gallen, Switzerland.
Cathomas R; Department of Oncology, Kantonsspital Graubünden, Chur, Switzerland.
Winterhalder R; Luzerner Kantonsspital, Luzerne, Switzerland.
Pokaż więcej
Corporate Authors:
Swiss Group for Clinical Cancer Research (SAKK)
Źródło:
BMC cancer [BMC Cancer] 2016 Oct 10; Vol. 16 (1), pp. 780. Date of Electronic Publication: 2016 Oct 10.
Typ publikacji:
Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Breast Neoplasms/*drug therapy
Administration, Metronomic ; Adult ; Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Bevacizumab/administration & dosage ; Biomarkers, Tumor ; Breast Neoplasms/metabolism ; Breast Neoplasms/mortality ; Breast Neoplasms/pathology ; Capecitabine/administration & dosage ; Cyclophosphamide/administration & dosage ; Female ; Humans ; Male ; Middle Aged ; Neoplasm Metastasis ; Neoplasm Staging ; Paclitaxel/administration & dosage ; Quality of Life ; Receptor, ErbB-2/metabolism ; Retreatment ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Adjuvant treatment recommendations for patients with ER-positive/HER2-negative early breast cancer by Swiss tumor boards using the 21-gene recurrence score (SAKK 26/10).
Autorzy:
Pestalozzi BC; Universitaetsspital Zuerich, Raemistrasse 100, 8091, Zurich, Switzerland. .
Tausch C; Brustzentrum Zuerich, Zurich, Switzerland.
Dedes KJ; Universitaetsspital Zuerich, Raemistrasse 100, 8091, Zurich, Switzerland.
Rochlitz C; Universitaetsspital Basel, Basel, Switzerland.
Zimmermann S; Hôpital Cantonal Fribourg, Fribourg, Switzerland.
von Moos R; Kantonsspital Graubuenden Chur, Chur, Switzerland.
Winterhalder R; Luzerner Kantonsspital, Lucerne, Switzerland.
Ruhstaller T; Breast Center St. Gallen, St. Gallen, Switzerland.
Mueller A; Kantonsspital Winterthur, Winterthur, Switzerland.
Buser K; Engeriedspital Bern, Bern, Switzerland.
Borner M; Spitalzentrum Biel, Biel, Switzerland.
Novak U; Inselspital Bern, Bern, Switzerland.
Nussbaum CU; Kantonsspital Olten, Olten, Switzerland.
Seifert B; Kantonsspital Baselland, Liestal, Switzerland.
Bigler M; SAKK Coordinating Center, Bern, Switzerland.
Bize V; SAKK Coordinating Center, Bern, Switzerland.
Vilei SB; SAKK Coordinating Center, Bern, Switzerland.
Rageth C; Brustzentrum Zuerich, Zurich, Switzerland.
Aebi S; Luzerner Kantonsspital, Lucerne, Switzerland.
Pokaż więcej
Corporate Authors:
Swiss Group for Clinical Cancer Research (SAKK)
Źródło:
BMC cancer [BMC Cancer] 2017 Apr 13; Vol. 17 (1), pp. 265. Date of Electronic Publication: 2017 Apr 13.
Typ publikacji:
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Antineoplastic Agents/*administration & dosage
Breast Neoplasms/*drug therapy
Receptor, ErbB-2/*genetics
Receptors, Estrogen/*genetics
Adult ; Aged ; Aged, 80 and over ; Antineoplastic Agents/therapeutic use ; Breast Neoplasms/genetics ; Chemotherapy, Adjuvant ; Clinical Decision-Making ; Cohort Studies ; Female ; Humans ; Middle Aged ; Risk Assessment ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Wyświetlanie 1-20 z 118

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies